156 RBC-derived, activating antigen carriers (SQZ AACs) prime potent T cell responses and drive tumor regression in vivo by Katarina Blagovic, Armon Sharei, Howard Bernstein, Scott Loughhead, Carolyne Smith, Lindsay Moore, Emrah Ilker Ozay

693 SQZ-AAC-HPV-101: initial data from a phase I dose escalation/expansion study of SQZ-AAC-HPV, a red blood cell-based therapeutic cancer vaccine for HPV16+ solid tumors by Emese Zsiros, Anthony F Shields, Howard Bernstein, Scott Loughhead, Richard T Maziarz, Shivani Joshi, Julia Jennings, Nathan Miselis, Marshelle S Warren, Victoria Villaflor, Rajwanth Veluswamy

170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming by Katarina Blagovic, Armon Sharei, Howard Bernstein, Katherine Seidl, Defne Yarar, Scott Loughhead, Emrah Ozay, Matthew Booty, David Soto, Olivia Pryor, Adam Stockmann, Disha Subramanya, Kelly Volk

692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors by Antonio Jimeno, Michael S Gordon, Howard Bernstein, Scott Loughhead, Jong Chul Park, Justin C Moser, Wade T Iams, Meredith Pelster, Kerry J Rodabaugh, Julia Jennings, Nathan Miselis, Marshelle S Warren, Victoria Villaflor, Melinda Morrison

594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16+ tumors treated with cell-based vaccine, SQZ-PBMC-HPV... by Neesha Dhani, Antonio Jimeno, Michael S Gordon, Matthew H Taylor, Howard Bernstein, Scott Loughhead, Joaquina Baranda, Udo Holtick, Jong Chul Park, Wade T Iams, Monica MitaSc, Kerry J Rodabaugh, E Amanda Duvall, Julia Jennings, Nathan Miselis, Marshelle S Warren

Targeted Delivery of Immunomodulators to Lymph Nodes by Jamil Azzi, Qian Yin, Mayuko Uehara, Shunsuke Ohori, Li Tang, Kaimin Cai, Takaharu Ichimura, Martina McGrath, Omar Maarouf, Eirini Kefaloyianni, Scott Loughhead, Jarolim Petr, Qidi Sun, Mincheol Kwon, Stefan Tullius, Ulrich H. von Andrian, Jianjun Cheng, Reza Abdi

Get full text

Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice by Katarina Blagovic, Carolyne K. Smith, Amritha Ramakrishnan, Lindsay Moore, David R. Soto, Zachary Thompson, Adam P. Stockmann, Sonia Kruszelnicki, Akshi Thakkar, Jason Murray, Sebastian Torres, Bersabel Wondimagegnhu, Roslyn Yi, Maisam Dadgar, Abdul M. Paracha, Claire Page, Louise Clear, Omer A. Chaudhry, Melissa Myint, Devin T. Bridgen, Jonathan B. Gilbert, Katherine J. Seidl, Armon Sharei, Scott Loughhead, Howard Bernstein, Defne Yarar

Get full text